back

Here you can find more information about RiboMed Project.

Tom Kirchhausen | Harvard Medical School


Michael Gotthardt | Max Delbrück Center for Molecular Medicine (MDC)


Adrian Krainer | Cold Spring Harbor Laboratory




Zandy Forbes | MeiraGTx




Ahmad Abou Tayoun | Al Jalila Genomics Center (Dubai)

Credits: João Solano



Rotem Karni | Hebrew University Hadassah Medical School


Alberto Kornblihtt | Buenos Aires University

Learn more about the work developed in Claus Azzalin Lab.


Learn more about the work developed in Nuno Morais Lab.


Learn more about the work developed in Sérgio de Almeida Lab.

Learn more about the policies and guidelines that related with intellectual property and technology transfer in our Inventor's Guide to Technology Transfer here.

This guide is intended to help iMM researchers that are interested in starting a start-up company based on their invention(s). The  guide covers an overview of the process needed to launch a new company, with a detailed description of each phase. It also includes tips for a start-up to succeed and the typically pitfalls to avoid. Click here.


Alberto Kornblihtt | Buenos Aires University

Vaccination in one of the most powerful weapons in the fight against the COVID-19 pandemic. Therefore, it is also one of the most debated subjects when it comes to herd immunity.

This video is supported by RiboMed. This project help iMM establish a strategic collaboration via twinning with partners from already well recognised communities working on RNA biology in the University of Oxford (UK), the Weizmann Institute of Science (Israel) and The Max Delbrück Center for Molecular Medicine (Germany).